)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Vaishali Pharma
Vaishali Pharma (VAISHALI) investor relations material
Vaishali Pharma Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary14 Aug, 2026
Executive summary
Board approved unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, along with the limited review reports from statutory auditors.
Annual Report and Director's Report for FY 2025-26 were approved, and the 19th AGM is scheduled for 24 September 2026 via video conferencing.
Appointment of scrutinizer for remote e-voting at the AGM was confirmed.
Financial highlights
Standalone revenue from operations for Q1 FY27 was ₹2,289.14 lakh, compared to ₹2,374.71 lakh in Q1 FY26 and ₹2,692.71 lakh in Q4 FY26.
Standalone net profit for Q1 FY27 was ₹148.97 lakh, up from ₹127.93 lakh in Q1 FY26 but down from ₹26.64 lakh in Q4 FY26.
Consolidated revenue from operations for Q1 FY27 was ₹2,289.14 lakh, with consolidated net profit at ₹154.54 lakh, including a ₹5.65 lakh share of profit from the associate.
Basic and diluted EPS for Q1 FY27 were ₹0.11 (standalone) and ₹0.12 (consolidated).
Outlook and guidance
No explicit forward-looking guidance provided, but the inclusion of the associate's results from September 2025 is expected to impact future consolidated performance.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vaishali Pharma
- Strong revenue and profit growth, with new associate consolidation and auditor caution on receivables.VAISHALI
Q4 25/26 - Q3 FY26 profit rose sequentially, preferential issue to raise ₹12.25 crore approved.VAISHALIQ3 25/26
- Strong revenue and profit growth with improved margins and positive operating cash flow.VAISHALIQ2 25/26
- Q1 FY26 saw higher revenue but lower net profit and EPS amid rising expenses.VAISHALIQ1 25/26
- Revenue and profit rose, but auditor flagged major uncertainty over receivables' recovery.VAISHALIQ4 24/25
- Revenue and net profit rose year-over-year, with strong equity growth and robust financing inflows.VAISHALIQ2 24/25
- Q1 FY25 saw higher revenue, a return to profit, and increased share capital.VAISHALIQ1 24/25
- Q3 FY25 revenue was flat, but net profit fell on higher costs; auditors found no misstatements.VAISHALIQ3 24/25
Next Vaishali Pharma earnings date
Q2 26/2713 Nov, 2026
Vaishali Pharma
Next Vaishali Pharma earnings date
Q2 26/2713 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage